CEACAM5 ANTIBODY-DRUG CONJUGATE FORMULATION

Provided are stabilized formulations of the human carcinoembryonic antigen-related cell adhesion molecule 5 (hCEACAM5)-targeted antibody-drug conjugate huMAb2-3-SPDB-DM4, as well as methods for making and using same.

Saved in:
Bibliographic Details
Main Authors BONESTEBE, Audrey, LEMAN, Marie, HUILLE, Sylvain, AUTHELIN, Jean-René, BENSAID, Fethi, MANACHE-ALBERICI, Lucie
Format Patent
LanguageEnglish
Published 29.06.2023
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:Provided are stabilized formulations of the human carcinoembryonic antigen-related cell adhesion molecule 5 (hCEACAM5)-targeted antibody-drug conjugate huMAb2-3-SPDB-DM4, as well as methods for making and using same.
Bibliography:Application Number: AU20210379882